CONFLICTING reports on the effectiveness and safety of statins can leave patients worried about possible side-effects.
A study at the Albert Einstein College of Medicine in New York suggested the cholesterol-lowering drugs may increase the risk of Type 2 diabetes by up to 30 per cent.
They have also been linked to muscle aches, memory loss, kidney problems and sleep disturbance, with concerns that the drugs are over-prescribed.
Consultant cardiologist Dr Aseem Malhotra says the “overwhelming majority” of people taking statins will not benefit. However others, including the British Heart Foundation, claim the drugs play an essential role in reducing the risk of another cardiovascular event for many of the 915,000 people in the UK who have survived a heart attack.
Dr Liam Smeeth, a professor of clinical epidemiology, says the benefit of statins has “been shown time and again”.
With experts unable to agree, more research is vital.